Abstract
The purpose of this study is to examine the effectiveness of topiramate in promoting weight loss among obese patients. The study was inspired by the fact that men and women, in addition to the stereotyped teenager, are affected by eating disorders. The general scope of this paper will comprise of the evaluation of the effectiveness of topiramate in weight loss amongst obese patients. The research achieves this through a review of past literature. In sum, the reviewed study found that the use of topiramate was associated with an increase in positive outcomes. Most of the positive outcomes were linked with weight reduction among overweight and obese patients. The review also revealed that the administration of the drug reduced the adverse effects of psychotic drugs minimized food cravings, alcohol, and smoking. Moreover, the combination of the drug with other antiepilepsy medications had more positive outcomes than when used as a monotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Research in Pharmaceutical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
